In the BioHarmony Drug Report Database

"Preview" Icon

Mitomycin

Jelmyto, Mitosol, Mitozytrex, Mutamycin (mitomycin) is a small molecule pharmaceutical. Mitomycin was first approved as Jelmyto on 1982-01-01. It is used to treat adenocarcinoma, colorectal neoplasms, pancreatic neoplasms, stomach neoplasms, and urinary bladder neoplasms in the USA. Mitomycin’s patents are valid until 2031-01-20 (FDA).

 

Trade Name

 

Jelmyto, Mitosol, Mitozytrex, Mutamycin
 

Common Name

 

mitomycin
 

ChEMBL ID

 

CHEMBL105
 

Indication

 

adenocarcinoma, colorectal neoplasms, pancreatic neoplasms, stomach neoplasms, urinary bladder neoplasms
 

Drug Class

 

Antibiotics (Streptomyces strains)

Image (chem structure or protein)

Mitomycin structure rendering